Literature DB >> 31548175

The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity.

Xu Jian1, Yuntao Liu2, Zhen Zhao1, Liyun Zhao3, Dawei Wang4, Qing Liu5.   

Abstract

Atherosclerosis (AS) is the main cause of ischemic cardiovascular, cerebrovascular and peripheral vascular diseases. Macrophage activity has been proven to play a critical role during the AS pathological process, which involves the adhesion, aggregation of mononuclear-macrophages, cell differentiation of M1/M2 macrophages as part of complex mechanisms occurring during lipid metabolism, apoptosis, autophagy, inflammation and immune reaction. Therefore, the development of effective AS treatments is likely to target macrophage activity. Certain herbal extracts (such as Salvia miltiorrhiza) have exhibited enormous potential for AS treatment in the past. Here, we aim to provide a summary on the current understanding of the type of action and the underlying target/pathway in macrophage regulation of certain herbal extracts used in Traditional Chinese Medicine for treatment of AS.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Chinese herbal medicine; Macrophage

Mesh:

Substances:

Year:  2019        PMID: 31548175     DOI: 10.1016/j.biopha.2019.109375

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Peptide-Based HDL as an Effective Delivery System for Lipophilic Drugs to Restrain Atherosclerosis Development.

Authors:  Junwei Gao; Ziyun Li; Jing Li; Ping Song; Jinsheng Yang; Wei Xiao; Ning Li; Ruodan Xu
Journal:  Int J Nanomedicine       Date:  2022-09-06

2.  Tongnao Decoction (TND) Alleviated Atherosclerosis by Playing Lowering Lipid, Anti-Inflammatory, and Antioxidant Roles.

Authors:  Hui Jiang; Jianli Wang; Li Sheng; Xiaoyu Xu; Bingmei Zhou; Luying Shen; Minghua Wu
Journal:  Oxid Med Cell Longev       Date:  2022-05-25       Impact factor: 7.310

Review 3.  Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.

Authors:  Xing Chang; Tian Zhang; Wenjin Zhang; Zhenyu Zhao; Jiahui Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-27       Impact factor: 6.543

4.  Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation.

Authors:  Mingtai Chen; Yong Luo; Ling Men; Bo Lin; Haidan Lin; Ying Li; Guofu Zhong; Xiaoling Zhong; Wenjun Fu; Hua Zhou; Guangdong Tong; Qiang Liu; Jienan Luan
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

5.  Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway.

Authors:  Zhuo Feng; Changyuan Wang; Qiang Meng; Jingjing Wu; Huijun Sun
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.

Authors:  Yuan Liu; Xu He; Zhibiao Di; Xia Du
Journal:  ACS Omega       Date:  2022-01-28

Review 7.  Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?

Authors:  Ana Clara Aprotosoaie; Alexandru-Dan Costache; Irina-Iuliana Costache
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

8.  The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway.

Authors:  Yue Zhang; Dongwei Wang; Kaili Wu; Xiaoqi Shao; Hongtao Diao; Zhiying Wang; Mengxian Sun; Xueying Huang; Yun Li; Xinyuan Tang; Meiling Yan; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-19       Impact factor: 2.650

9.  Network pharmacology and experimental analysis to reveal the mechanism of Dan-Shen-Yin against endothelial to mesenchymal transition in atherosclerosis.

Authors:  Mengyun Hong; Yubiao Wu; Haiyi Zhang; Jinchao Gu; Juanjuan Chen; Yancheng Guan; Xiude Qin; Yu Li; Jiahui Cao
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

Review 10.  Macrophage-Based Therapies for Atherosclerosis Management.

Authors:  Renyi Peng; Hao Ji; Libo Jin; Sue Lin; Yijiang Huang; Ke Xu; Qinsi Yang; Da Sun; Wei Wu
Journal:  J Immunol Res       Date:  2020-01-29       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.